(Q40973893)

25 September 2017

1 reference

title

Atrial fibrillation, anticoagulation, and stroke (English)

1 reference

25 September 2017

1 reference

1 reference

Morley J

1

1 reference

25 September 2017

Marinchak R

series ordinal

2

1 reference

25 September 2017

Rials SJ

series ordinal

3

1 reference

25 September 2017

Kowey P

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

American Journal of Cardiology

25 September 2017

published in

1 reference

25 September 2017

volume

77

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

38A-44A

1 reference

Arterial embolism: a 44 year perspective

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Epidemiologic features of chronic atrial fibrillation: the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Management of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Atrial fibrillation 1992. Management strategies in flux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Clinical features of paroxysmal atrial fibrillation an observation of 94 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Embolic complications in paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Cerebral computed tomography in paroxysmal atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

THE CHANGES IN CARDIAC OUTPUT WITH REVERSION OF ATRIAL FIBRILLATION TO SINUS RHYTHM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

"Cardioversion" of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Anticoagulation for cardioversion of atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Quinidine therapy of chronic auricular fibrillation. The occurrence and mechanism of syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Stroke Prevention in Atrial Fibrillation Study. Final results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Canadian atrial fibrillation anticoaguiation (CAFA) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

Complications of warfarin therapy monitored by the International Normalized Ratio versus the prothrombin time ratio.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2989116-3

10.1016/S0002-9149(97)89116-3

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference